(19)
(11) EP 1 900 331 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
27.10.2010 Bulletin 2010/43

(45) Mention of the grant of the patent:
14.07.2010 Bulletin 2010/28

(21) Application number: 07022779.8

(22) Date of filing: 17.10.2001
(51) International Patent Classification (IPC): 
A61B 17/12(2006.01)

(54)

Non-overlapping spherical three-dimensional vaso-occlusive coil

Nicht überlappende, kugelförmige, dreidimensionale, gefässverschliessende Spule

Spirale vaso-occlusive tridimensionnelle sphérique non chevauchante


(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

(30) Priority: 18.10.2000 US 691954

(43) Date of publication of application:
19.03.2008 Bulletin 2008/12

(62) Application number of the earlier application in accordance with Art. 76 EPC:
01979857.8 / 1326543

(73) Proprietor: Boston Scientific Scimed, Inc.
Maple Grove, MN 55311 (US)

(72) Inventors:
  • Teoh, Clifford
    Los Altos, CA 94024-6114 (US)
  • Wallace, Michael, P.
    Pleasanton, CA 94566 (US)

(74) Representative: Vossius & Partner 
Siebertstrasse 4
81675 München
81675 München (DE)


(56) References cited: : 
WO-A-00/12016
WO-A-01/93780
WO-A-99/09893
US-A- 5 980 554
US-A- 6 063 070
WO-A-00/21443
WO-A-98/02100
US-A- 5 749 891
US-A- 6 010 517
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).